Literature DB >> 26190896

Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery.

Seigo Takaya1, Hiroaki Saito1, Masahide Ikeguchi1.   

Abstract

BACKGROUND: Surgery has been reported to suppress cell-mediated immunity; however, the detailed mechanisms responsible for this remain unclear. This study determined the expression of lymphocyte activation gene 3 (LAG-3) and programmed cell death 1 (PD-1) in lymphocytes following surgery for gastric cancer.
METHODS: LAG-3 and PD-1 expression on both CD4+ and CD8+ T cells obtained pre- and post-operatively from gastric cancer patients were evaluated by multicolor flow cytometry.
RESULTS: The total lymphocyte count decreased rapidly from preoperative levels, reaching a minimum on postoperative day 1 and remaining significantly decreased on days 3 and 7. PD-1(+)CD4(+) T cells significantly increased, reaching a maximum on postoperative day 1 and remaining significantly elevated on day 3. PD-1(+)CD8(+) T cells significantly increased and reached a maximum on day 7 before returning to the preoperative level on day 30. There were no statistically significant differences in the frequency of LAG-3(+)CD4(+) or LAG-3(+)CD8(+) T cells after surgery. There were significant positive correlations between PD-1 and LAG-3 expression on both CD4(+) andCD8(+) T cells.
CONCLUSION: PD-1 and LAG-3 expression on both CD4(+) and CD8(+) T cells was up-regulated and might be related to impaired cell-mediated immunity after surgery for gastric cancer.

Entities:  

Keywords:  T-cell; gastric cancer; lymphocyte activation gene 3; programmed cell death 1

Year:  2015        PMID: 26190896      PMCID: PMC4502424     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  33 in total

1.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.

Authors:  Daria Trabattoni; Marina Saresella; Mara Biasin; Adriano Boasso; Luca Piacentini; Pasquale Ferrante; Haidong Dong; Renato Maserati; Gene M Shearer; Lieping Chen; Mario Clerici
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

Review 2.  The PD-1-PD-L pathway in immunological tolerance.

Authors:  Taku Okazaki; Tasuku Honjo
Journal:  Trends Immunol       Date:  2006-02-24       Impact factor: 16.687

Review 3.  Immunostimulatory monoclonal antibodies for cancer therapy.

Authors:  Ignacio Melero; Sandra Hervas-Stubbs; Martin Glennie; Drew M Pardoll; Lieping Chen
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

4.  Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand.

Authors:  B Huard; P Gaulard; F Faure; T Hercend; F Triebel
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

6.  Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Authors:  Junko Matsuzaki; Sacha Gnjatic; Paulette Mhawech-Fauceglia; Amy Beck; Austin Miller; Takemasa Tsuji; Cheryl Eppolito; Feng Qian; Shashikant Lele; Protul Shrikant; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

7.  Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells.

Authors:  Malgorzata Kisielow; Jan Kisielow; Giuseppina Capoferri-Sollami; Klaus Karjalainen
Journal:  Eur J Immunol       Date:  2005-07       Impact factor: 5.532

8.  Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.

Authors:  Lukas Baitsch; Amandine Legat; Leticia Barba; Silvia A Fuertes Marraco; Jean-Paul Rivals; Petra Baumgaertner; Céline Christiansen-Jucht; Hanifa Bouzourene; Donata Rimoldi; Hanspeter Pircher; Nathalie Rufer; Maurice Matter; Olivier Michielin; Daniel E Speiser
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

10.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

View more
  25 in total

1.  Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.

Authors:  Kozo Miyatani; Hiroaki Saito; Yusuke Kono; Yuki Murakami; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2017-09-15       Impact factor: 2.549

2.  Postoperative ratio of the maximum C-reactive protein level to the minimum peripheral lymphocyte count as a prognostic indicator for gastric cancer patients.

Authors:  Yusuke Kono; Hiroaki Saito; Yuki Murakami; Yuji Shishido; Hirohiko Kuroda; Tomoyuki Matsunaga; Manabu Yamamoto; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2018-10-13       Impact factor: 2.549

3.  Intra-Abdominal Complications after Curative Gastrectomies Worsen Prognoses of Patients with Stage II-III Gastric Cancer.

Authors:  Kader A T M Abdul; Yuki Murakami; Miwa Yoshimoto; Kazunari Onishi; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Shuichi Takano; Naruo Tokuyasu; Tomohiro Osaki; Hiroaki Saito; Masahide Ikeguchi
Journal:  Yonago Acta Med       Date:  2016-09-12       Impact factor: 1.641

4.  The combined expressions of B7H4 and ACOT4 in cancer-associated fibroblasts are related to poor prognosis in patients with gastric carcinoma.

Authors:  Qing Li; Yu'e Yang; Xin Jiang; Yufen Jin; Jingyi Wu; Yan Qin; Xiaowei Qi; Yang Cheng; Yong Mao; Dong Hua
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 5.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

Review 6.  Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.

Authors:  Xiaojun Liu; Zhongxia Yang; Olivier Latchoumanin; Liang Qiao
Journal:  Therap Adv Gastroenterol       Date:  2016-07-21       Impact factor: 4.409

7.  Characterization of LAG-3, CTLA-4, and CD8+ TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Wenjia Wang; Donglai Chen; Yuhuan Zhao; Ting Zhao; Junmiao Wen; Yiming Mao; Chang Chen; Yonghua Sang; Yongsheng Zhang; Yongbing Chen
Journal:  Ann Transl Med       Date:  2019-12

Review 8.  Understanding LAG-3 Signaling.

Authors:  Luisa Chocarro; Ester Blanco; Miren Zuazo; Hugo Arasanz; Ana Bocanegra; Leticia Fernández-Rubio; Pilar Morente; Gonzalo Fernández-Hinojal; Miriam Echaide; Maider Garnica; Pablo Ramos; Ruth Vera; Grazyna Kochan; David Escors
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

Review 9.  Lymphocyte-activation gene-3, an important immune checkpoint in cancer.

Authors:  Yayi He; Christopher J Rivard; Leslie Rozeboom; Hui Yu; Kim Ellison; Ashley Kowalewski; Caicun Zhou; Fred R Hirsch
Journal:  Cancer Sci       Date:  2016-08-25       Impact factor: 6.716

10.  Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.

Authors:  An Na Seo; Byung Woog Kang; Oh Kyoung Kwon; Ki Bum Park; Seung Soo Lee; Ho Young Chung; Wansik Yu; Han Ik Bae; Seong Woo Jeon; Hyojeung Kang; Jong Gwang Kim
Journal:  Br J Cancer       Date:  2017-10-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.